ab
Unsere Experten im Bereich Life Science unterstützen Wissenschaftler und Ingenieure dabei, die Herausforderungen in jedem Entwicklungsstadium ihrer Arbeit zu meistern. Unser Angebot umfasst fortschrittlichste Technologien sowie hochwertige Produkte und Lösungen. Anwendung finden diese in der F
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be safe for human beings and efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraTherapeutics currently performs preclinical safety and efficacy studies for our modified Vesicular Stomatitis Virus (VSV-GP) and aims to conduct first clinical trials in cancer patients in the near future.
AOP Orphan Pharmaceuticals AG is an international pharmaceutical company with a focus on rare and special diseases. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna. This has been made possible by a high level of investment in research and development and a strong orientation towards the needs of especially the patients and their families but also the doctors and health care professionals.
F4 Pharma, a clinical-stage biopharmaceutical company developing F06, an anti-inflammatory therapeutic that has shown to improve vascular integrity, FX06 is a substance discovered and developed in the Medical University of Vienna and has a dual mode of action: it is reducing the capillary leak and has anti-inflammatory efficacy. In Covid-19 by reducing pulmonary vascular hyperpermeability, FX06 is supposed to lead to improved lung function and reduced time of mechanical ventilation.
QPS is a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services since 1995. Our mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities.
Bayer has core competencies in the fields of health care and nutrition. We address the challenges presented by a growing and aging global population and are committed to drive sustainable development, generate a positive impact with our businesses and create value through innovation and growth. Bayer Austria is a subsidiary of Bayer AG, based in Vienna, where about 190 employees are responsible for marketing, sales, medical information on Bayer-products and clinical studies.
GSK is a leading global research-driven healthcare company with approximately 94,000 employees in 96 countries. At GSK Austria, about 80 employees are working to make a wide range of prescription drugs and vaccines available to as many people as possible in Austria - focusing on transformative therapies in oncology, severe asthma and HIV. For the seventh year in a row, GSK is number one in the Access to Medicine Index and GSK Austria is a member of Transparency International Austria.
AstraZeneca Österreich GmbH is one of the leading pharmaceutical companies in Austria and develops, manufactures and markets innovative drugs for the treatment of diseases in the fields of cardiovascular and metabolism, oncology, respiratory diseases and for the treatment of infectious and autoimmune diseases.
Haplogen, founded 2010 is a Vienna based, privately owned biotechnology company. Based on a novel mechanism Haplogen develops proprietary small molecule therapeutic compounds for the treatment of diseases that lead to adipositas and obesity.
Croma-Pharma GmbH, kurz Croma, ist ein international tätiges, pharmazeutisches Unternehmen mit Sitz in Leobendorf, Österreich. Seit über 40 Jahren werden innovative Arzneimittel und Medizinprodukte für die Bereiche Ophthalmologie, Orthopädie und ästhetische Dermatologie entwickelt, produziert und vertrieben. Damit leistet Croma seit vier Jahrzehnten wichtige Beiträge zur Verbesserung der Gesundheit und Lebensqualität.
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. We have leveraged our expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Vienna Textile Lab fabricates organic colours made by naturally occurring bacteria in order to provide the most sustainable, wholesome and environmentally friendly alternative to conventional synthetic colours. Using Vienna Textile Lab colours to dye your textiles means to act responsible and thoughtful. We help designers use new type of materials, methods and concepts in the textile business. Vienna Textile Lab makes dyeing go easy on human and ecological resources.